These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16259723)

  • 1. The kallikrein-kinin system: from mediator of inflammation to modulator of cardioprotection.
    Sharma JN
    Inflammopharmacology; 2005; 12(5-6):591-6. PubMed ID: 16259723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular properties of the kallikrein-kinin system.
    Sharma JN; Sharma J
    Curr Med Res Opin; 2002; 18(1):10-7. PubMed ID: 11999140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic targets and prototype therapeutics in the kallikrein-kinin system: bradykinin receptor agonists or antagonists.
    Sharma JN; Al-Sherif GJ
    ScientificWorldJournal; 2006 Oct; 6():1247-61. PubMed ID: 17041716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic prospects for bradykinin receptor agonists in the treatment of cardiovascular diseases.
    Sharma JN; Thani RB
    IDrugs; 2004 Oct; 7(10):926-34. PubMed ID: 15478018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kallikrein-kinin system: current and future pharmacological targets.
    Moreau ME; Garbacki N; Molinaro G; Brown NJ; Marceau F; Adam A
    J Pharmacol Sci; 2005 Sep; 99(1):6-38. PubMed ID: 16177542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kallikrein/kinin system and kinin antagonists in trauma.
    Rodell TC
    Immunopharmacology; 1996 Jun; 33(1-3):279-83. PubMed ID: 8856162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kallikrein-kinin system in acute pancreatitis: potential of B(2)-bradykinin antagonists and kallikrein inhibitors.
    Griesbacher T
    Pharmacology; 2000 Apr; 60(3):113-20. PubMed ID: 10754447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The plasma and tissue kininogen-kallikrein-kinin system: role in the cardiovascular system.
    Marcondes S; Antunes E
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Jan; 3(1):33-44. PubMed ID: 15638742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinin receptor agonism restores hindlimb postischemic neovascularization capacity in diabetic mice.
    Desposito D; Potier L; Chollet C; Gobeil F; Roussel R; Alhenc-Gelas F; Bouby N; Waeckel L
    J Pharmacol Exp Ther; 2015 Feb; 352(2):218-26. PubMed ID: 25398240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction.
    Chao J; Bledsoe G; Yin H; Chao L
    Biol Chem; 2006 Jun; 387(6):665-75. PubMed ID: 16800727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the renal kallikrein-kinin system in diabetic nephropathy.
    Riad A; Zhuo JL; Schultheiss HP; Tschöpe C
    Curr Opin Nephrol Hypertens; 2007 Jan; 16(1):22-6. PubMed ID: 17143067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology and cardiovascular implications of the kinin-kallikrein system.
    Dendorfer A; Wolfrum S; Dominiak P
    Jpn J Pharmacol; 1999 Apr; 79(4):403-26. PubMed ID: 10361880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kinin system in hypertensive pathophysiology.
    Sharma JN
    Inflammopharmacology; 2013 Feb; 21(1):1-9. PubMed ID: 22527353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice.
    Messadi-Laribi E; Griol-Charhbili V; Gaies E; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):489-93. PubMed ID: 18307747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular biology in regulation of kidney functions: Kallikrein-kinin system (bradykinin)].
    Yoshida H; Taniguchi S; Ura N
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():199-202. PubMed ID: 16523887
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of the kallikrein-kinin system in type I diabetes (insulitis).
    Zuccollo A; Cueva F; Frontera M; Navarro M; Catanzaro O
    Immunopharmacology; 1996 Jun; 33(1-3):349-50. PubMed ID: 8856183
    [No Abstract]   [Full Text] [Related]  

  • 17. [A role of kallikrein-kinin system in gut diseases].
    Zelawski W; Witalińska-Labuzek J; Stadnicki A
    Wiad Lek; 2005; 58(5-6):331-4. PubMed ID: 16238127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation of kallikrein-kinin system in different pathologies.
    Costa-Neto CM; Dillenburg-Pilla P; Heinrich TA; Parreiras-e-Silva LT; Pereira MG; Reis RI; Souza PP
    Int Immunopharmacol; 2008 Feb; 8(2):135-42. PubMed ID: 18182216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent antihypertrophic effect of the bradykinin B2 receptor system on the renal vasculature.
    Tsuchida S; Miyazaki Y; Matsusaka T; Hunley TE; Inagami T; Fogo A; Ichikawa I
    Kidney Int; 1999 Aug; 56(2):509-16. PubMed ID: 10432390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kallikrein-kinin in stroke, cardiovascular and renal disease.
    Chao J; Chao L
    Exp Physiol; 2005 May; 90(3):291-8. PubMed ID: 15653716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.